Mirae Asset Global ETFs Holdings’s Oric Pharmaceuticals ORIC Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$493K	Sell	39,188 -1,869	-5%	-$21.2K	﹤0.01%	1897
2025 Q4	$335K	Buy	41,057 +9,686	+31%	+$111K	﹤0.01%	2097
2025 Q3	$375K	Buy	31,371 +4,713	+18%	+$49.6K	﹤0.01%	2008
2025 Q2	$271K	Sell	26,658 -13,543	-34%	-$90.9K	﹤0.01%	2121
2025 Q1	$226K	Buy	40,201 +3,131	+8%	+$27.4K	﹤0.01%	2262
2024 Q4	$299K	Buy	37,070 +704	+2%	+$6.46K	﹤0.01%	2173
2024 Q3	$374K	Buy	36,366 +12,467	+52%	+$123K	﹤0.01%	2061
2024 Q2	$168K	Buy	+23,899	New	+$214K	﹤0.01%	2341

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ORIC Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Oric Pharmaceuticals (ORIC) stake by 4.6% in Q1 2026, selling an estimated $21.2K and leaving 39,188 shares worth $493K. The position accounts for ﹤0.01% of the portfolio, ranked #1897.

Mirae Asset Global ETFs Holdings first reported a position in ORIC in Q2 2024 and has held it in 8 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

Mirae Asset Global ETFs Holdings held 39,188 shares of Oric Pharmaceuticals worth $493K as of Q1 2026.
Mirae Asset Global ETFs Holdings sold 1,869 Oric Pharmaceuticals shares in Q1 2026, an estimated $21.2K.
Oric Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1897 holding.
Mirae Asset Global ETFs Holdings first reported a position in Oric Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.